Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
interferon beta-1a interferon alpha/beta receptor 1 biotech NA drugbank , DGIDB Condylomata Acuminata[MeSHID:D003218]
Multiple Sclerosis
Relapsing-Remitting[MeSHID:D020529]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Coronavirus Infections[MeSHID:D018352]
Multiple Sclerosis[MeSHID:D009103]
Disease[MeSHID:D004194]		 2.65 approved,investigational agonist
interferon beta-1a interferon alpha/beta receptor 1 biotech NA drugbank , DGIDB Condylomata Acuminata[MeSHID:D003218]
Multiple Sclerosis
Relapsing-Remitting[MeSHID:D020529]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Coronavirus Infections[MeSHID:D018352]
Multiple Sclerosis[MeSHID:D009103]
Disease[MeSHID:D004194]		 NA approved,investigational agonist
interferon beta-1a interferon alpha/beta receptor 1 biotech NA drugbank , DGIDB Condylomata Acuminata[MeSHID:D003218]
Multiple Sclerosis
Relapsing-Remitting[MeSHID:D020529]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Multiple Sclerosis[MeSHID:D009103]		 NA approved,investigational agonist
interferon beta-1a interferon alpha/beta receptor 1 biotech NA drugbank , DGIDB Condylomata Acuminata[MeSHID:D003218]
Multiple Sclerosis
Relapsing-Remitting[MeSHID:D020529]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Multiple Sclerosis[MeSHID:D009103]		 2.65 approved,investigational agonist
interferon beta-1a interferon alpha/beta receptor 2 biotech NA drugbank , DGIDB Condylomata Acuminata[MeSHID:D003218]
Multiple Sclerosis
Relapsing-Remitting[MeSHID:D020529]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Multiple Sclerosis[MeSHID:D009103]		 2.65 approved,investigational agonist
interferon beta-1a interferon alpha/beta receptor 2 biotech NA drugbank , DGIDB Condylomata Acuminata[MeSHID:D003218]
Multiple Sclerosis
Relapsing-Remitting[MeSHID:D020529]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Coronavirus Infections[MeSHID:D018352]
Multiple Sclerosis[MeSHID:D009103]
Disease[MeSHID:D004194]		 2.65 approved,investigational agonist
interferon beta-1a interferon-beta NA Successful target TTD , DGIDB Condylomata Acuminata[MeSHID:D003218]
Multiple Sclerosis
Relapsing-Remitting[MeSHID:D020529]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Multiple Sclerosis[MeSHID:D009103]		 NA approved unknown
interferon beta-1a interferon-beta NA Successful target TTD , DGIDB Condylomata Acuminata[MeSHID:D003218]
Multiple Sclerosis
Relapsing-Remitting[MeSHID:D020529]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Coronavirus Infections[MeSHID:D018352]
Multiple Sclerosis[MeSHID:D009103]
Disease[MeSHID:D004194]		 NA approved unknown
click here to return to the previous page